Peyronie's Disease
Discreet, non-surgical treatment for Peyronie's disease — no medications, no injections, no surgery.
Our Approach
With electromagnetic teletherapy, we can break down the scar tissue that has formed. This is a painless procedure that involves no medications, surgery, or needles. Numerous studies have proven to have equal to or even better results when compared to injections.
Contact us to learn more about our Peyronie's treatment at our medical centre in Knoxville, TN.
Frequently Asked Questions: Peyronie's & LDRT
Do I need a referral? +
No. You can call us directly. If you have an orthopedic surgeon, primary care physician, or rheumatologist, we coordinate with them.
Does it hurt? +
No. You feel nothing during treatment. No needle, no injection, no anesthesia.
Are there side effects? +
Rare. Some patients notice mild, temporary skin redness. No systemic side effects.
Will it cause cancer? +
The dose used for benign conditions is 10 to 25 times lower than the dose used to treat cancer. Long-term studies in Germany — where LDRT has been used for decades — show no increased cancer risk. We do not treat patients under 40 except in specific circumstances.
How quickly will I feel better? +
Most patients begin noticing relief between 6 and 12 weeks after their final session. About 70% report meaningful improvement.
How long does relief last? +
Typically 12 to 24 months. A second course can be given if symptoms return.
What if it doesn't work for me? +
LDRT is not a guarantee. About 20–30% of patients see limited or no benefit. We will tell you this honestly during your consultation. The treatment does not interfere with future options including surgery.
Is it covered by insurance? +
Most major insurance is accepted — Medicare, BCBS, Aetna, Cigna, Humana, UnitedHealthcare, Tricare, and others. Our office handles all insurance pre-authorization.
How many sessions will I need? +
Most benign musculoskeletal conditions require 6 to 8 weekday sessions, scheduled on consecutive business days so you complete a full course in under two weeks. Each session takes about 15 minutes. Some skin and fibrotic conditions follow different protocols — your consultation will clarify what fits your situation.
Scientific references
Niewald M, Wenzlawowicz KV, Fleckenstein J, et al. (2018). Risk-adapted radiotherapy for Peyronie's disease. Strahlentherapie und Onkologie.
Open on PubMedIncrocci L, Wijnmaalen A, Slob AK, et al. (2008). Low-dose external-beam radiotherapy for early-stage Peyronie's disease. Radiation Oncology.
Open on PubMed